Cardlytics Cuts 15% of Workforce, Targets $12.2M Annualized Expense Savings
CDLX is trading near its 52-week low of $1.26 (2.4% above the low).
Summary
Cardlytics is cutting about 30 full-time employees, roughly 15% of its workforce, aiming for approximately $12.2 million in annualized operating expense savings at a cost of about $0.7 million in severance. The move follows a weak Q3 with revenue down 30% and thin cash relative to debt.
Key Events · Corporate Governance and Compliance · CDLX
-
Workforce Cut of About 15%
Under a plan announced November 16, 2026, Cardlytics will eliminate approximately 30 full-time employees, about 15% of its current workforce.
-
$12.2M Annualized Savings Targeted
The plan, together with other cost-reduction measures, is expected to cut operating expenses by approximately $12.2 million on an annualized basis.
-
$0.7M Severance Charge in Q4
Non-recurring charges of approximately $0.7 million for severance and related costs are expected mostly in the quarter ending December 31, 2026, with implementation and cash payments substantially complete by year-end.
-
Follows Weak Q3 and Covenant Waiver
The restructuring follows Q3 revenue of $32.9 million, down 30% year-over-year, Adjusted EBITDA of just $0.4 million, and a lender covenant waiver on 2026 Adjusted EBITDA, as previously disclosed.
Analysis · CDLX · Technology
This is a survival-driven cost cut, not a growth initiative. Cardlytics is eliminating about 30 jobs, roughly 15% of staff, to remove approximately $12.2 million of annualized operating expense. The backdrop explains the urgency: Q3 revenue fell 30% year-over-year, Adjusted EBITDA was only $0.4 million, and cash of $29.9 million stands against $194.7 million of debt and a lender covenant waiver. Severance of $0.7 million is small, but the savings loom large relative to a company this size, and the plan is meant to be substantially complete by December 31, 2026.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDLX was trading at $1.29 on NASDAQ in the Technology sector, with a market capitalization of approximately $7.9M. The 52-week trading range was $1.26 to $15.55. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.